Frank Porfido

Frank Porfido is a seasoned finance executive with a wealth of experience in leading small to mid-size Pharma Business Units/Franchises and overseeing the Finance function for a commercial staged Pharma Biotech.

He specializes in Financial and Managerial Accounting, Financial Planning & Analysis, Strategic Planning, Mergers & Acquisitions, International Finance, Transfer Pricing, SEC Reporting, SOX controls, Medical spending, Risk Management and Insurance, operating at all organizational levels, with further expertise in Board Management.

His educational background encompasses a BS in CPA Prep from Pace University - Lubin School of Business and an MBA in Finance from Fairleigh Dickinson University.

Throughout his career, Frank Porfido has held key financial positions in various notable organizations, including being the Chief Financial Officer at TYME Technologies Inc., Vice President of Finance at UroGen Pharma, Head of Global Finance & Operations at Novartis, Global Head of Finance - OTM at Novartis, Senior Director BP&A at Novartis, Sr. VP Planning at Movado, IDTI US CFO at Novartis, Executive Director Finance US at Novartis Oncology, Director Of Brand Operations at Schein Pharmaceutical, Inc, Finance US at Ciba Pharma, and Senior Financial Analyst at both Ciba-Geigy and Nabisco.